Journal article icon

Journal article

DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines

Abstract:

Vaccination remains the most effective and essential prophylactic tool against infectious diseases. Enormous efforts have been made to develop effective vaccines against malaria but successes remain so far limited. Novel adjuvants may offer a significant advantage in the development of malaria vaccines, in particular if combined with inherently immunogenic platforms, such as virus-like particles (VLP). Dioleoyl phosphatidylserine (DOPS), which is expressed on the outer surface of apoptotic ce...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.3390/diseases6040107

Authors


Cabral-Miranda, G More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
Jenner Institute
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
Jenner Institute
Storni, FL More by this author
Roesti, ES More by this author
Expand authors...
Publisher:
MDPI Publisher's website
Journal:
Diseases Journal website
Volume:
6
Issue:
4
Pages:
Article: 107
Publication date:
2018-11-21
Acceptance date:
2018-11-16
DOI:
ISSN:
2079-9721
Pubs id:
pubs:955418
URN:
uri:fde3abbb-98e2-402c-817d-9270694cc061
UUID:
uuid:fde3abbb-98e2-402c-817d-9270694cc061
Local pid:
pubs:955418

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP